Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Boehringer Ingelheim
Queensland Health

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 073580

« Back to Dashboard

NDA 073580 describes EMVERM, which is a drug marketed by Impax Labs Inc and is included in one NDA. It is available from four suppliers. Additional details are available on the EMVERM profile page.

The generic ingredient in EMVERM is mebendazole. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the mebendazole profile page.

Summary for 073580

Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for NDA: 073580

Medical Subject Heading (MeSH) Categories for 073580

Suppliers and Packaging for NDA: 073580

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EMVERM mebendazole TABLET, CHEWABLE;ORAL 073580 ANDA Amedra Pharmaceuticals LLC 52054-107 52054-107-01 1 BLISTER PACK in 1 CARTON (52054-107-01) > 1 TABLET, CHEWABLE in 1 BLISTER PACK
EMVERM mebendazole TABLET, CHEWABLE;ORAL 073580 ANDA Physicians Total Care, Inc. 54868-3732 54868-3732-2 1 BLISTER PACK in 1 BOTTLE, DISPENSING (54868-3732-2) > 6 TABLET, CHEWABLE in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, CHEWABLE;ORALStrength100MG
Approval Date:Jan 4, 1995TE:RLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Farmers Insurance
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: